Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Sauer

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2015
DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastasesWilfried Budach, Christiane Matuschek, Edwin Bölke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2013
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trialHendrik Andreas Wolff, Lena-Christin Conradi, Tim Beissbarth, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2011
Quality assurance for clinical studies in regional deep hyperthermiaGregor Bruggmoser, Stefan Bauchowitz, Richard Canters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trialsVincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2015
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancerVincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
JAMA Surgery|June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical TrialJulia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
The Lancet. Oncology|May 26, 2012
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trialClaus Rödel, Torsten Liersch, Heinz Becker, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2015
DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastasesWilfried Budach, Christiane Matuschek, Edwin Bölke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2013
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trialHendrik Andreas Wolff, Lena-Christin Conradi, Tim Beissbarth, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2011
Quality assurance for clinical studies in regional deep hyperthermiaGregor Bruggmoser, Stefan Bauchowitz, Richard Canters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trialsVincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trialRebekka Kosmala, Emmanouil Fokas, Michael Flentje, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2015
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancerVincenzo Valentini, Ruud G P M van Stiphout, Guido Lammering, et al.
JAMA Surgery|June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical TrialJulia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
The Lancet. Oncology|May 26, 2012
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trialClaus Rödel, Torsten Liersch, Heinz Becker, et al.
Pageof 15